To Compare the Mean Duration of Third Stage of Labour Between Intraumbilical and Intravenous Oxytocin.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Duration of the third stage labour
Study Overview
Brief Summary
There is always a debate for choosing the best method for management of the third stage of labour (TSL) in the general practice for reducing the duration of TSL. Although intravenous oxytocin is more extensively used in general practice for managing TSL than intraumbilical, it still needs to be properly investigated among local populations and in local settings.
Detailed Description
The findings of this study could identify the better route of oxytocin injection that could guide clinicians and health providers to opt for the better route in their routine practice for the management of TSL in order to reduce the morbidity and mortality of the patients, especially for developing countries like Pakistan, where most of the deliveries are conducted at peripheral or rural centers by a nurse, midwife, or a trained dai.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Females aged 18-40 years
- •With spontaneous vaginal delivery
- •Singleton pregnancy
- •Gestational age >37 weeks
- •Parity l-5
- •Any gravidity
Exclusion Criteria
- •Females with intrauterine fetal death
- •Malpresentation
- •Multiple pregnancy
- •Polyhydramnios
- •Premature rupture of membranes
- •Medical disorders and hypertensive disorders of pregnancy
Arms & Interventions
Intraumbilical oxytocin group
Patients were given 10 U of intraumbilical oxytocin, diluted in 10 mL of normal saline.
Intervention: Intraumbilical oxytocin (Drug)
Intravenous oxytocin group
Patients received 20 U of intravenous oxytocin diluted in 500 mL of normal saline.
Intervention: Intravenous oxytocin (Drug)
Outcomes
Primary Outcomes
Duration of the third stage labour
Time Frame: 30 minutes
The duration of the third stage labour was measured from the completed delivery of the newborn until the completed delivery of the placenta.
Secondary Outcomes
No secondary outcomes reported